National Health Act 1953 Amendment special arrangements under subsection 100(1) Chemotherapy Pharmaceuticals Access Program (No. PB 105 of 2010) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 105 of 2010
Amendment special arrangements under subsection 100(1) of the National Health Act 1953
I, DAVID LEARMONTH, Deputy Secretary, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated 29th October 2010
DAVID LEARMONTH
Deputy Secretary
Department of Health and Ageing
Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program
1 Commencement
This instrument commences on 1 November 2010.
2 Amendment of PB 55 of 2009
Schedule 1 amends PB 55 of 2009.
Schedule 1 Amendments
Schedule 1, after item dealing with Paclitaxel, nanoparticle albumin-bound
insert in the columns in the order indicated:
| Palonosetron | Management of nausea and vomiting associated with cytotoxic chemotherapy being used to treat malignancy which occurs within 48 hours of chemotherapy administration |
Schedule 2, after item dealing with Paclitaxel, nanoparticle albumin-bound
insert in the columns in the order indicated:
| Palonosetron | Injection 250 micrograms (as hydrochloride) in 5mL | Injection | 1 | .. | Aloxi |
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0